Here, the authors report a cryo-EM structure of the human TAS2R14 in complex with its signaling partner gustducin, and bound to an anti-inflammatory drug flufenamic acid (FFA).

The fund seeks to benefit from the inherent volatility in the natural resource sector, using low net and gross positioning to achieve superior risk adjusted returns with low correlation to major asset ...